We are live on ! Find out more
PTC

Philadelphia Trust Company Portfolio holdings

AUM $1.42B
1-Year Est. Return 43.77%
This Fund
S&P 500
This Quarter Est. Return
+7.56%
1 Year Est. Return
+43.77%
3 Year Est. Return
+141.5%
5 Year Est. Return
+176.17%
10 Year Est. Return
+554.31%
AUM
$1.29B
AUM Growth
+$41.2M
Cap. Flow
-$24.8M
Cap. Flow %
-1.93%
Top 10 Hldgs %
42.44%
Holding
248
New
10
Increased
65
Reduced
79
Closed
19

Top Sells

Rank Stock Value
1
WIRE
Encore Wire Corp
WIRE
+$12.6M
2
NVDA icon
NVIDIA
NVDA
+$11.5M
3
UL icon
Unilever
UL
+$7.37M
4
DOW icon
Dow Inc
DOW
+$6.66M
5
CVS icon
CVS Health
CVS
+$6.22M

Sector Composition

Rank Sector Weight
1 Technology 34.69%
2 Industrials 14.22%
3 Healthcare 13.22%
4 Financials 9.7%
5 Communication Services 7.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GAB icon
51
Gabelli Equity Trust
GAB
$1.79B
$6.13M 0.48%
1,178,109
-21,160
-2% -$114K
CDRE icon
52
Cadre Holdings
CDRE
$1.41B
$6.11M 0.47%
182,008
+101,180
+125% +$3.33M
MRK icon
53
Merck
MRK
$318B
$5.84M 0.45%
47,202
+173
+0.4% +$22.3K
STAG icon
54
STAG Industrial
STAG
$7.19B
$5.77M 0.45%
160,033
+5,139
+3% +$183K
VTRS icon
55
Viatris
VTRS
$18.9B
$5.38M 0.42%
506,559
+96,436
+24% +$1.07M
VIG icon
56
Vanguard Dividend Appreciation ETF
VIG
$114B
$5.31M 0.41%
29,066
-275
-0.9% -$49.5K
GILD icon
57
Gilead Sciences
GILD
$165B
$5.26M 0.41%
76,617
-6,673
-8% -$445K
PR
58
Permian Resources
PR
$16.9B
$5.06M 0.39%
313,500
+128,500
+69% +$2.13M
ELAN icon
59
Elanco Animal Health
ELAN
$11.1B
$4.59M 0.36%
317,799
+23,132
+8% +$370K
JNJ icon
60
Johnson & Johnson
JNJ
$625B
$4.45M 0.35%
30,409
+243
+0.8% +$36.1K
VO icon
61
Vanguard Morningstar Mid-Cap ETF
VO
$109B
$3.96M 0.31%
65,420
-1,620
-2% -$98.4K
LLY icon
62
Eli Lilly
LLY
$1.06T
$3.85M 0.3%
4,254
+10
+0.2% +$8K
ORCL icon
63
Oracle
ORCL
$423B
$3.76M 0.29%
26,635
+4,800
+22% +$596K
IWB icon
64
iShares Russell 1000 ETF
IWB
$50.2B
$3.55M 0.28%
11,946
+11,218
+1,541% +$3.22M
DGICA icon
65
Donegal Group Class A
DGICA
$714M
$3.46M 0.27%
268,765
-7,950
-3% -$106K
PM icon
66
Philip Morris
PM
$295B
$3.44M 0.27%
33,948
+53
+0.2% +$5.18K
VRNT
67
DELISTED
Verint Systems
VRNT
$3.38M 0.26%
+105,000
New +$3.35M
CI icon
68
Cigna
CI
$74.6B
$3.36M 0.26%
10,163
KHC icon
69
Kraft Heinz
KHC
$30B
$3.23M 0.25%
100,288
-26,415
-21% -$941K
HLIT icon
70
Harmonic Inc
HLIT
$1.28B
$3.12M 0.24%
+265,000
New +$2.99M
T icon
71
AT&T
T
$163B
$2.97M 0.23%
155,571
ITA icon
72
iShares US Aerospace & Defense ETF
ITA
$15B
$2.87M 0.22%
21,735
-346
-2% -$45.9K
CVX icon
73
Chevron
CVX
$366B
$2.83M 0.22%
18,070
-211
-1% -$33.6K
PKBK icon
74
Parke Bancorp
PKBK
$405M
$2.83M 0.22%
162,435
GSK icon
75
GSK
GSK
$106B
$2.78M 0.22%
72,162
-460
-0.6% -$19.4K

Similar funds

Philadelphia Trust Company's Q2 2024 Portfolio in Review

As of Q2 2024, Philadelphia Trust Company held 248 positions worth $1.29B, up 3.3% from $1.25B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Philadelphia Trust Company's Q2 2024 filing shows 10 new, 65 increased, 79 reduced and 19 closed positions. Its largest new stake was Freeport-McMoran: 129,756 shares worth $6.31M. The largest sale was Encore Wire Corp, an estimated $12.6M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 31% a quarter earlier, followed by Industrials and Healthcare.

  • Philadelphia Trust Company's largest Q2 2024 buy was Freeport-McMoran: 129,756 shares worth $6.31M.
  • Philadelphia Trust Company added most to IQVIA in Q2 2024, an estimated $4.1M increase.
  • Philadelphia Trust Company's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $11.5M.
  • Philadelphia Trust Company fully exited Encore Wire Corp in Q2 2024, selling an estimated $12.6M.
  • Philadelphia Trust Company's ten largest holdings make up 42% of its $1.29B portfolio in Q2 2024.
  • Philadelphia Trust Company opened 10 new positions and closed 19 in Q2 2024.
  • Philadelphia Trust Company's portfolio value rose 3.3% quarter-over-quarter to $1.29B.

Based on Philadelphia Trust Company's 13F filing for Q2 2024, filed 13 Aug 2024.